Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Non-cash Items (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Non-cash Items for 13 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items changed N/A to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.7 million for FY2025, N/A changed from the prior year.
  • Non-cash Items for Q4 2025 was $1.7 million at Plus Therapeutics, up from $1103.0 in the prior quarter.
  • The five-year high for Non-cash Items was $1.7 million in Q4 2025, with the low at $149.0 in Q1 2021.
  • Average Non-cash Items over 5 years is $450510.8, with a median of $154830.0 recorded in 2024.
  • The sharpest move saw Non-cash Items surged 739575.84% in 2022, then tumbled 99.66% in 2023.
  • Over 5 years, Non-cash Items stood at $343.0 in 2021, then skyrocketed by 195786.88% to $671892.0 in 2022, then tumbled by 98.96% to $7000.0 in 2023, then skyrocketed by 1481.06% to $110674.0 in 2024, then skyrocketed by 1421.57% to $1.7 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $1.7 million, $1103.0, and $198986.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.